非典型子宫内膜病变保留生育联合治疗后使用来曲唑与左炔诺孕酮宫内系统的卵巢刺激评估:回顾性病例对照研究
回顾性病例对照研究纳入75例,比较保留生育联合治疗后接受来曲唑和左炔诺孕酮宫内系统(LNG-IUS)在位卵巢刺激的15例患者与两组对照的获卵数及成熟卵数,差异无统计学意义;9例胚胎移植者临床妊娠率55.6%、累积活产率44.4%、流产率20%;3例非典型子宫内膜增生(AEH)患者取环后分别于3、6、16个月复发(12%)。
要点
- 保留生育联合治疗后以LNG-IUS在位加来曲唑行卵巢刺激,获卵数与成熟卵数与对照无显著差异。
- 9例胚胎移植者临床妊娠率55.6%、累积活产率44.4%、流产率20%。
- 3例AEH患者取环后分别于3、6、16个月复发(12%)。
核心结论
- 对要求保留未来生育力的AEH或局限于子宫内膜的早期子宫内膜癌女性,可建议(弱推荐)采用保留生育的宫腔镜联合治疗及后续来曲唑加LNG-IUS在位的卵巢刺激。
研究设计与样本
- 回顾性病例对照研究,纳入接受保留生育「联合」治疗及来曲唑加LNG-IUS在位卵巢刺激的女性,采用「三步法」宫腔镜技术。
- 完全缓解后行卵巢刺激并冻存成熟卵母细胞,取出LNG-IUS后移植胚胎。
- 共分析75例:研究组15例为保留生育治疗完全缓解后行卵母细胞冻存者;对照A组30例为接受IVF/ICSI卵巢刺激的健康不孕女性;对照B组30例为接受来曲唑卵巢刺激的乳腺癌患者。
主要发现
- 研究组与对照A组、对照B组在获卵数和成熟卵母细胞数上均无统计学显著差异。
- 9例接受胚胎移植的患者中,临床妊娠率55.6%、累积活产率44.4%、流产率20%。
- 3例AEH患者取出LNG-IUS以尝试胚胎移植后分别于3、6、16个月复发(12%)。
临床怎么用
- 作者认为,对要求保留未来生育力的AEH或早期子宫内膜癌女性,可建议(弱推荐)保留生育的宫腔镜联合治疗及后续来曲唑加LNG-IUS在位的卵巢刺激。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is ovarian stimulation with levonorgestrel intrauterine system (LNG-IUS) in situ and co-treatment with letrozole safe and effective in patients undergoing fertility-sparing combined treatment for atypical endometrial hyperplasia (AEH) or early endometrial cancer limited to the endometrium? DESIGN: Retrospective case-control study recruiting women who had undergone fertility-sparing 'combined' treatment and ovarian stimulation with letrozole and LNG-IUS in situ. The 'three steps' hysteroscopic technique was used. Once complete response was achieved, the ovaries were stimulated, and mature oocytes cryopreserved. The LNG-IUS was removed, and embryos transferred. A comparative analysis was conducted between the two control groups of the initial outcomes of ART (number of oocytes and MII oocytes retrieved): healthy infertile women undergoing ovarian stimulation for IVF/ICSI (control group A); and patients diagnosed with breast cancer who underwent ovarian stimulation with letrozole (control group B). RESULTS: Of the 75 patients analysed, 15 underwent oocyte cryopreservation after achieving a complete response to fertility-sparing treatment (study group); 30 patients in control group A and B, respectively. No statistically significant differences were observed in retrieved oocytes and mature oocytes between the study and control groups. In the nine patients who underwent embryo transfer, clinical pregnancy (55.6%), cumulative live birth (44.4%) and miscarriage (20%) rates were reported. In three patients with AEH, recurrence occurred (12%) at 3, 6 and 16 months after removing the LNG-IUS to attempt embryo transfer, respectively. CONCLUSION: Fertility-sparing hysteroscopic combined treatment and subsequent ovarian stimulation with letrozole and LNG-IUS in situ could be suggested to women with AEH or early endometrial cancer who ask for future fertility preservation.
引用
- Gallo A, Di Spiezio Sardo A, Conforti A, et al. Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study. Reprod Biomed Online. 2023. PMID: 38430660. doi:10.1016/j.rbmo.2023.103750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。